These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3490630)

  • 1. Effect of amphetamine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice.
    Sershen H; Mason MF; Reith ME; Hashim A; Lajtha A
    Neuropharmacology; 1986 Aug; 25(8):927-30. PubMed ID: 3490630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nicotine and amphetamine on the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice.
    Sershen H; Mason MF; Reith ME; Hashim A; Lajtha A
    Neuropharmacology; 1986 Nov; 25(11):1231-4. PubMed ID: 3491964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice.
    Heikkila RE; Cabbat FS; Manzino L; Duvoisin RC
    Neuropharmacology; 1984 Jun; 23(6):711-3. PubMed ID: 6611514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity.
    Heikkila RE; Hess A; Duvoisin RC
    Life Sci; 1985 Jan; 36(3):231-6. PubMed ID: 3917525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent depletion of striatal dopamine and its metabolites in mice by TMMP, an analogue of MPTP.
    Fuller RW; Hemrick-Luecke SK
    J Pharm Pharmacol; 1987 Aug; 39(8):667-9. PubMed ID: 2888865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity.
    Fuller RW; Hemrick-Luecke SK
    J Pharm Pharmacol; 1989 Jul; 41(7):492-3. PubMed ID: 2570859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to cigarette smoke does not decrease the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Perry TL; Hansen S; Jones K
    Neurosci Lett; 1987 Feb; 74(2):217-20. PubMed ID: 3494963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP].
    Averkin RG; Korshunov VA; Shchegolevskiĭ NV; Mats VN; Markevich VA; Grigor'ian GA; Bazian AS
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):109-19. PubMed ID: 20352690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
    Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM
    Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1).
    Sheng JG; Xu DL; Yu HZ; Xu XR; Tang QM
    Life Sci; 1987 May; 40(20):2007-10. PubMed ID: 2437428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and biochemical changes following acute administration of MPTP and MPP+.
    Tadano T; Satoh N; Sakuma I; Matsumura T; Kisara K; Arai Y; Kinemuchi H
    Life Sci; 1987 Mar; 40(13):1309-18. PubMed ID: 2436017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity.
    Mayer RA; Walters AS; Heikkila RE
    Eur J Pharmacol; 1986 Jan; 120(3):375-7. PubMed ID: 2868908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW; Hemrick-Luecke SK
    Life Sci; 1985 Sep; 37(12):1089-96. PubMed ID: 3875779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources.
    Heikkila RE
    Eur J Pharmacol; 1985 Oct; 117(1):131-3. PubMed ID: 3878793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl.
    Saitoh T
    J Neurol Sci; 1988 Feb; 83(2-3):161-6. PubMed ID: 3258627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
    J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues.
    Fries DS; de Vries J; Hazelhoff B; Horn AS
    J Med Chem; 1986 Mar; 29(3):424-7. PubMed ID: 3485197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice.
    Fuller RW; Hemrick-Luecke SK
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):687-90. PubMed ID: 3878976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.